AMBRX BIOPHARMA INC's ticker is AMAM and the CUSIP is 02290A102. A total of 51 filers reported holding AMBRX BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $114,122,424 | -27.9% | 9,923,689 | +3.2% | 6.66% | -24.9% |
| Q2 2023 | $158,281,911 | +208660.1% | 9,616,155 | +13.1% | 8.87% | +77.6% |
| Q1 2023 | $75,820 | +1329.5% | 8,500,000 | +263.8% | 4.99% | +1306.5% |
| Q4 2022 | $5,304 | -99.8% | 2,336,389 | 0.0% | 0.36% | +101.7% |
| Q3 2022 | $2,523,000 | -61.7% | 2,336,389 | -6.0% | 0.18% | -64.7% |
| Q2 2022 | $6,589,000 | -35.7% | 2,486,386 | 0.0% | 0.50% | -36.7% |
| Q1 2022 | $10,244,000 | -54.4% | 2,486,386 | 0.0% | 0.79% | -41.0% |
| Q4 2021 | $22,452,000 | -32.2% | 2,486,386 | 0.0% | 1.34% | -0.7% |
| Q3 2021 | $33,097,000 | -29.6% | 2,486,386 | 0.0% | 1.34% | -15.8% |
| Q2 2021 | $47,032,000 | – | 2,486,386 | – | 1.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,486,386 | $22,452,000 | 1.34% |
| Fosun International Ltd | 1,932,591 | $17,451,000 | 1.00% |
| Octagon Capital Advisors LP | 336,868 | $3,042,000 | 0.59% |
| Artal Group S.A. | 2,152,291 | $19,435,000 | 0.53% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,057,735 | $9,551,000 | 0.18% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,923,700 | $17,371,000 | 0.03% |
| FMR LLC | 3,855,025 | $34,811,000 | 0.00% |
| TUDOR INVESTMENT CORP ET AL | 20,143 | $182,000 | 0.00% |
| CAAS CAPITAL MANAGEMENT LP | 13,068 | $118,000 | 0.00% |
| BlackRock Inc. | 2,869,486 | $25,912,000 | 0.00% |